A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects with Acute Spinal Cord Injury

Grants and Contracts Details

StatusFinished
Effective start/end date7/2/12 → 7/31/15

Funding

  • Asubio Pharmaceuticals Incorporated: $27,150.00